These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 6202963

  • 1. Felodipine, a new vasodilating drug: blood pressure, cardiac, renal, and humoral effects in hypertensive patients.
    Leonetti G, Gradnik R, Terzoli L, Fruscio M, Rupoli L, Zanchetti A.
    J Cardiovasc Pharmacol; 1984; 6(3):392-8. PubMed ID: 6202963
    [Abstract] [Full Text] [Related]

  • 2. Monotherapy with felodipine, a new calcium antagonist, in mild and moderate hypertension.
    Hamilton DV, Barnes PC, Bowles RM, Rajaratnam DV, Comerford MB, Ginks WR, Ginks SE, Goves JR, Grabau WJ, Malcolm JP.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S111-3. PubMed ID: 2455107
    [Abstract] [Full Text] [Related]

  • 3. Effects of felodipine on blood pressure and humoral factors in sodium-replete humans at rest and during exercise.
    Lijnen P, Hespel P, Fagard R, Staessen J, M'Buyamba-Kabangu JR, Moerman E, Amery A.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S122-5. PubMed ID: 2455111
    [Abstract] [Full Text] [Related]

  • 4. Effects of different sodium intakes on the antihypertensive and renal effects of single oral doses of nifedipine in hypertensive patients.
    Leonetti G, Rupoli L, Sangiorgio P, Gradnik R, Cuspidi C, Bolla G, Zanchetti A.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S138-9. PubMed ID: 2455116
    [Abstract] [Full Text] [Related]

  • 5. Antihypertensive and water and sodium balance effects of felodipine, a new vasodilating calcium antagonist, in hypertensive patients.
    Leonetti G, Fruscio M, Terzoli L, Rupoli L, Gradnik R, Sampieri L, Cuspidi C, Boselli L, Bolla G, Zanchetti A.
    Drugs; 1985; 29 Suppl 2():185-91. PubMed ID: 3987547
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The calcium channel blocker nitrendipine in single- and multiple-agent antihypertensive regimens: preliminary report of a multicenter study.
    Weber MA, Drayer JI.
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1077-84. PubMed ID: 6085371
    [Abstract] [Full Text] [Related]

  • 8. Differential effects of felodipine and nifedipine on 24-h blood pressure and left ventricular mass.
    Myers MG, Leenen FH, Tanner J.
    Am J Hypertens; 1995 Jul; 8(7):712-8. PubMed ID: 7546497
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J, Karas M, Nguyen P, Cartier P, Wistaff R, Toal CB, Nadeau R, Larochelle P.
    J Hypertens; 1998 Nov; 16(11):1357-69. PubMed ID: 9856375
    [Abstract] [Full Text] [Related]

  • 13. Differential effects of once-daily antihypertensive drugs on blood pressure, left ventricular mass and sympathetic activity: Nifedipine-GITS versus felodipine-ER versus enalapril.
    Leenen FH, Myers MG, Joyner CD, Toal CB.
    Can J Cardiol; 2002 Dec; 18(12):1285-93. PubMed ID: 12518180
    [Abstract] [Full Text] [Related]

  • 14. Renal and antihypertensive effects of felodipine in hypertensive patients.
    Leonetti G, Gradnik R, Terzoli L, Fruscio M, Rupoli L, Cuspidi C, Sampieri L, Zanchetti A.
    J Hypertens Suppl; 1985 Dec; 3(3):S161-3. PubMed ID: 2856695
    [Abstract] [Full Text] [Related]

  • 15. Antihypertensive effect of a new calcium channel blocker, FK 235, in essential hypertension.
    Mizuno K, Hashimoto S, Yabe R, Kunii N, Niimura S, Tani M, Watari H, Fukuchi S.
    Res Commun Chem Pathol Pharmacol; 1986 Apr; 52(1):3-15. PubMed ID: 3520729
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
    Fagan TC, Haggert BE, Liss C.
    Clin Ther; 1994 Apr; 16(4):634-46. PubMed ID: 7982251
    [Abstract] [Full Text] [Related]

  • 17. The effect of 8 weeks treatment with the calcium antagonist felodipine on blood pressure, heart rate, working capacity, plasma renin activity, plasma angiotensin II, urinary catecholamines and aldosterone in patients with essential hypertension.
    Katzman PL, Hulthén UL, Hökfelt B.
    Br J Clin Pharmacol; 1986 Jun; 21(6):633-40. PubMed ID: 3527242
    [Abstract] [Full Text] [Related]

  • 18. Comparison of cardiovascular, renal, and humoral effects of acute administration of two calcium channel blockers in normotensive and hypertensive subjects.
    Leonetti G, Cuspidi C, Sampieri L, Terzoli L, Zanchetti A.
    J Cardiovasc Pharmacol; 1982 Jun; 4 Suppl 3():S319-24. PubMed ID: 6184561
    [Abstract] [Full Text] [Related]

  • 19. [Acute treatment of arterial hypertension using calcium antagonists: comparison between diltiazem and nifedipine].
    Arigoni C, Rusca A, Pusterla CE, Beretta-Piccoli C.
    Schweiz Med Wochenschr; 1987 Jul 25; 117(30):1152-7. PubMed ID: 3313686
    [Abstract] [Full Text] [Related]

  • 20. Effects of calcium antagonism on the resting and exercise-stimulated renin-aldosterone axis.
    Hespel P, Lijnen P, Fiocchi R, Lissens W, Moerman E, Amery A.
    Methods Find Exp Clin Pharmacol; 1987 Jul 25; 9(7):461-7. PubMed ID: 3316874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.